DK1505069T3 - Fremgangsmåde til rensning af moxidectin ved hjælp af krystallisation - Google Patents

Fremgangsmåde til rensning af moxidectin ved hjælp af krystallisation

Info

Publication number
DK1505069T3
DK1505069T3 DK04254592.1T DK04254592T DK1505069T3 DK 1505069 T3 DK1505069 T3 DK 1505069T3 DK 04254592 T DK04254592 T DK 04254592T DK 1505069 T3 DK1505069 T3 DK 1505069T3
Authority
DK
Denmark
Prior art keywords
crystallization
moxidectin
purifying
purifying moxidectin
Prior art date
Application number
DK04254592.1T
Other languages
English (en)
Inventor
Isidoro Hector Sorokin
Raimonda Paola Di
Chin-Liang Chou
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Application granted granted Critical
Publication of DK1505069T3 publication Critical patent/DK1505069T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK04254592.1T 2003-08-07 2004-07-30 Fremgangsmåde til rensning af moxidectin ved hjælp af krystallisation DK1505069T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49331703P 2003-08-07 2003-08-07

Publications (1)

Publication Number Publication Date
DK1505069T3 true DK1505069T3 (da) 2012-07-23

Family

ID=33552111

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04254592.1T DK1505069T3 (da) 2003-08-07 2004-07-30 Fremgangsmåde til rensning af moxidectin ved hjælp af krystallisation

Country Status (12)

Country Link
US (2) US7348417B2 (da)
EP (1) EP1505069B1 (da)
JP (1) JP4653979B2 (da)
KR (1) KR101123018B1 (da)
CN (1) CN100439375C (da)
CY (1) CY1113198T1 (da)
DK (1) DK1505069T3 (da)
ES (1) ES2387390T3 (da)
PL (1) PL1505069T3 (da)
PT (1) PT1505069E (da)
SI (1) SI1505069T1 (da)
TW (1) TWI343254B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR074482A1 (es) 2008-12-04 2011-01-19 Merial Ltd Derivados dimericos de avermectina y milbemicina
EP2512467A1 (en) 2009-12-17 2012-10-24 Merial Limited Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
BR122020002199B1 (pt) * 2011-12-02 2021-01-19 Merial, Inc. formulações de moxidectina injetável de ação prolongada e novas formas de cristal de moxidectina
PE20151726A1 (es) 2013-04-12 2015-11-18 Zoetis Services Llc Formulaciones veterinarias estables de combinacion de lactonas macrociclicas e imidazotiazoles
CN103601735B (zh) * 2013-11-08 2015-12-09 大连九信生物化工科技有限公司 一种提纯莫西克汀的方法
KR101484481B1 (ko) * 2014-08-07 2015-01-20 주식회사 다림바이오텍 Pde-5 저해제를 포함하는 설하분무제의 제조방법 및 이에 의하여 제조된 설하분무용 조성물
CN105001232A (zh) * 2015-07-08 2015-10-28 安徽省皖北药业股份有限公司 一种莫昔克丁的提纯方法
CN105646521B (zh) * 2016-03-28 2018-10-02 河北圣雪大成制药有限责任公司 一种莫西克汀的结晶方法
CN107383053B (zh) * 2017-07-25 2019-11-05 宁夏泰瑞制药股份有限公司 一种莫西菌素粗品的纯化方法
KR102412089B1 (ko) * 2021-09-13 2022-06-22 주식회사 세라수 Dmts의 정제방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106994A (en) 1984-06-05 1992-04-21 American Cyanamid Company Agents and method of production thereof
US5169956A (en) 1984-06-05 1992-12-08 American Cyanamid Company Macrolide antibiotic compounds
US5317030A (en) 1984-06-05 1994-05-31 American Cyanamid Company Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
US5198464A (en) 1984-06-05 1993-03-30 American Cyanamid Company Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents
CA1296329C (en) * 1986-06-06 1992-02-25 Derek R. Sutherland Macrolide compounds
US4916154A (en) 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
US4988824A (en) 1989-09-11 1991-01-29 Maulding Donald R Process for the preparation of 23-(C1-C6 alkyloxime)-LL-F28249 compounds
US5478951A (en) * 1994-06-22 1995-12-26 American Cyanamid Company Method for the purification of 23-E isomers of 23-imino derivatives of LL-F28249 compounds

Also Published As

Publication number Publication date
EP1505069B1 (en) 2012-07-04
US7348417B2 (en) 2008-03-25
US20050033041A1 (en) 2005-02-10
US7645863B2 (en) 2010-01-12
TW200509903A (en) 2005-03-16
JP2005053916A (ja) 2005-03-03
SI1505069T1 (sl) 2012-08-31
CN1626536A (zh) 2005-06-15
KR101123018B1 (ko) 2012-03-15
KR20050016205A (ko) 2005-02-21
EP1505069A1 (en) 2005-02-09
PT1505069E (pt) 2012-08-07
TWI343254B (en) 2011-06-11
CN100439375C (zh) 2008-12-03
CY1113198T1 (el) 2016-04-13
ES2387390T3 (es) 2012-09-21
JP4653979B2 (ja) 2011-03-16
PL1505069T3 (pl) 2012-12-31
US20080119543A1 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
DK1647529T3 (da) Fremgangsmåde til oprensing af spildevand
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1720571T3 (da) Fremgangsmåde til behandling af hæmolytisk sygdom
DK1799662T3 (da) Fremgangsmåder til kemisk syntese og oprensning af diaminophenothiaziniumforbindelser, herunder methylthioniniumchlorid (MTC)
EP1814982A4 (en) IMPROVED METHOD FOR CLEANING VIRUSES
DK1720802T3 (da) Okidation af organiske forbindelser ved højt pH
DK1807673T3 (da) Fremgangsmåde til fremstilling af sporbar ammunition
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
DK1813678T3 (da) Fremgangsmåde til fremstilling af glycogen
DK1840125T3 (da) Mellemprodukter til fremstilling af dioxan-2-alkylcarbamater
DK1590061T3 (da) Fremgangsmåde til rensning af alfa-1-antitrypsin
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DK1578731T3 (da) Fremgangsmåde til fremstilling af pyrimidinforbindelser
NO20054876D0 (no) Substituerte 4-fenyltetrahydroisokinoliner, fremgangsmate for fremstilling derav, deres anvendelse som medikament og medikament inneholdende slike forbindelser
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
DK1740534T3 (da) Fremgangsmåde til rensning af mesotrion
DK1682541T3 (da) Fremgangsmåde til fremstilling af tiotropiumsalte
DK1656365T3 (da) Fremgangsmåde til fremstilling af enantiomerisk rent mirtazapin
PL1505069T3 (pl) Sposób oczyszczania moksydektyny przez krystalizację
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1692137T3 (da) Fremgangsmåde til fremstilling af tubulinininhibitorer
DK1510501T3 (da) Krystalliseret IM-11-fast stof af strukturtypen LTA og fremgangsmåde til fremstilling deraf